120 related articles for article (PubMed ID: 32829393)
1. Reference-adjusted and standardized all-cause and crude probabilities as an alternative to net survival in population-based cancer studies.
Lambert PC; Andersson TM; Rutherford MJ; Myklebust TÅ; Møller B
Int J Epidemiol; 2020 Oct; 49(5):1614-1623. PubMed ID: 32829393
[TBL] [Abstract][Full Text] [Related]
2. Non-parametric estimation of reference adjusted, standardised probabilities of all-cause death and death due to cancer for population group comparisons.
Rutherford MJ; Andersson TM; Myklebust TÅ; Møller B; Lambert PC
BMC Med Res Methodol; 2022 Jan; 22(1):2. PubMed ID: 34991487
[TBL] [Abstract][Full Text] [Related]
3. Direct modelling of age standardized marginal relative survival through incorporation of time-dependent weights.
Lambert PC; Syriopoulou E; Rutherford MR
BMC Med Res Methodol; 2021 Apr; 21(1):84. PubMed ID: 33894741
[TBL] [Abstract][Full Text] [Related]
4. Conditional crude probabilities of death for English cancer patients.
Wong KF; Lambert PC; Mozumder SI; Broggio J; Rutherford MJ
Br J Cancer; 2019 Nov; 121(10):883-889. PubMed ID: 31601960
[TBL] [Abstract][Full Text] [Related]
5. Marginal measures and causal effects using the relative survival framework.
Syriopoulou E; Rutherford MJ; Lambert PC
Int J Epidemiol; 2020 Apr; 49(2):619-628. PubMed ID: 31953948
[TBL] [Abstract][Full Text] [Related]
6. Estimating the crude probability of death due to cancer and other causes using relative survival models.
Lambert PC; Dickman PW; Nelson CP; Royston P
Stat Med; 2010 Mar; 29(7-8):885-95. PubMed ID: 20213719
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends in net and crude probability of death from cancer and other causes in the Australian population, 1984-2013.
Dasgupta P; Cramb S; Kou K; Yu XQ; Baade PD
Cancer Epidemiol; 2019 Oct; 62():101568. PubMed ID: 31330423
[TBL] [Abstract][Full Text] [Related]
8. Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.
He VY; Condon JR; Baade PD; Zhang X; Zhao Y
Popul Health Metr; 2017 Jan; 15(1):1. PubMed ID: 28095862
[TBL] [Abstract][Full Text] [Related]
9. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival.
Cronin KA; Feuer EJ
Stat Med; 2000 Jul; 19(13):1729-40. PubMed ID: 10861774
[TBL] [Abstract][Full Text] [Related]
10. [WebSurvCa: web-based estimation of death and survival probabilities in a cohort].
Clèries R; Ameijide A; Buxó M; Vilardell M; Martínez JM; Alarcón F; Cordero D; Díez-Villanueva A; Yasui Y; Marcos-Gragera R; Vilardell ML; Carulla M; Galceran J; Izquierdo Á; Moreno V; Borràs JM
Gac Sanit; 2018; 32(5):492-495. PubMed ID: 29357998
[TBL] [Abstract][Full Text] [Related]
11. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
[TBL] [Abstract][Full Text] [Related]
12. Fair comparisons of cause-specific and relative survival by accounting for the systematic removal of patients from risk-sets.
Wells M; Rutherford MJ; Lambert PC
Cancer Epidemiol; 2023 Oct; 86():102408. PubMed ID: 37591148
[TBL] [Abstract][Full Text] [Related]
13. Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models.
Eloranta S; Lambert PC; Andersson TM; Czene K; Hall P; Björkholm M; Dickman PW
BMC Med Res Methodol; 2012 Jun; 12():86. PubMed ID: 22726307
[TBL] [Abstract][Full Text] [Related]
14. Quantifying differences in breast cancer survival between England and Norway.
Lambert PC; Holmberg L; Sandin F; Bray F; Linklater KM; Purushotham A; Robinson D; Møller H
Cancer Epidemiol; 2011 Dec; 35(6):526-33. PubMed ID: 21606014
[TBL] [Abstract][Full Text] [Related]
15. Inverse probability weighting and doubly robust standardization in the relative survival framework.
Syriopoulou E; Rutherford MJ; Lambert PC
Stat Med; 2021 Nov; 40(27):6069-6092. PubMed ID: 34523751
[TBL] [Abstract][Full Text] [Related]
16. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based study.
Quaresma M; Coleman MP; Rachet B
Lancet; 2015 Mar; 385(9974):1206-18. PubMed ID: 25479696
[TBL] [Abstract][Full Text] [Related]
17. Trends in probabilities of death owing to cancer and owing to other causes in patients with colon cancer.
Jooste V; Bouvier AM; Bossard N; Uhry Z; Coureau G; Remontet L; Dantony E;
Eur J Gastroenterol Hepatol; 2019 May; 31(5):570-576. PubMed ID: 30829692
[TBL] [Abstract][Full Text] [Related]
18. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
19. On standardized relative survival.
Sasieni P; Brentnall AR
Biometrics; 2017 Jun; 73(2):473-482. PubMed ID: 27554303
[TBL] [Abstract][Full Text] [Related]
20. Direct modeling of the crude probability of cancer death and the number of life years lost due to cancer without the need of cause of death: a pseudo-observation approach in the relative survival setting.
Kipourou DK; Perme MP; Rachet B; Belot A
Biostatistics; 2022 Jan; 23(1):101-119. PubMed ID: 32374817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
